Jennifer Jackson

Jennifer A. Jackson currently works at Oncopeptides AB, as Independent Director from 2018, TESARO UK Ltd., as Director from 2015, and American Society of Clinical Oncology, Inc., as Member.
Dr. Jackson also formerly worked at Bristol Myers Squibb Co., as Executive Director-Regulatory Affairs, Repligen Corp., as Scientist, Vertex Pharmaceuticals, Inc., as Vice President-Regulatory Affairs, Biogen, Inc., as Vice President-Regulatory Affairs, Cubist Pharmaceuticals LLC, as Senior Vice President-Regulatory Affairs, Bioverativ Therapeutics, Inc., as Vice President-Regulatory & Clinical Compliance in 2011, and Tesaro, Inc., as Senior VP-Regulatory Affairs & Quality Assurance.
Dr. Jackson received her undergraduate degree from The Reed Institute and doctorate degree from Cornell University.